Q3 Earnings Estimate for MMSI Issued By Barrington Research

Merit Medical Systems, Inc. (NASDAQ:MMSI) – Equities researchers at Barrington Research cut their Q3 2025 EPS estimates for shares of Merit Medical Systems in a research note issued to investors on Wednesday, February 26th. Barrington Research analyst M. Petusky now forecasts that the medical instruments supplier will post earnings of $0.93 per share for the quarter, down from their prior forecast of $0.96. Barrington Research currently has a “Outperform” rating and a $111.00 price target on the stock. The consensus estimate for Merit Medical Systems’ current full-year earnings is $3.37 per share. Barrington Research also issued estimates for Merit Medical Systems’ FY2025 earnings at $3.70 EPS and FY2026 earnings at $4.00 EPS.

MMSI has been the subject of a number of other reports. Needham & Company LLC decreased their target price on Merit Medical Systems from $122.00 to $116.00 and set a “buy” rating for the company in a research report on Wednesday, February 26th. Canaccord Genuity Group reduced their price objective on Merit Medical Systems from $128.00 to $127.00 and set a “buy” rating for the company in a research note on Wednesday, February 26th. Piper Sandler reaffirmed an “overweight” rating and set a $116.00 target price (up from $114.00) on shares of Merit Medical Systems in a research report on Wednesday, January 29th. Raymond James lifted their price target on shares of Merit Medical Systems from $105.00 to $110.00 and gave the company an “outperform” rating in a research report on Tuesday, December 31st. Finally, Wells Fargo & Company decreased their price target on shares of Merit Medical Systems from $120.00 to $117.00 and set an “overweight” rating for the company in a research note on Wednesday, February 26th. Two research analysts have rated the stock with a hold rating, eight have given a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $110.78.

Merit Medical Systems Trading Down 1.1 %

MMSI opened at $101.89 on Monday. The company has a fifty day moving average price of $103.09 and a two-hundred day moving average price of $100.26. Merit Medical Systems has a 1-year low of $70.70 and a 1-year high of $111.45. The company has a market cap of $5.99 billion, a P/E ratio of 49.95, a price-to-earnings-growth ratio of 2.34 and a beta of 0.87. The company has a current ratio of 5.36, a quick ratio of 3.82 and a debt-to-equity ratio of 0.57.

Hedge Funds Weigh In On Merit Medical Systems

A number of hedge funds and other institutional investors have recently modified their holdings of the business. NewSquare Capital LLC bought a new stake in Merit Medical Systems during the fourth quarter worth $32,000. Kohmann Bosshard Financial Services LLC purchased a new stake in shares of Merit Medical Systems during the 4th quarter valued at $52,000. Federated Hermes Inc. raised its stake in shares of Merit Medical Systems by 139.1% during the 4th quarter. Federated Hermes Inc. now owns 655 shares of the medical instruments supplier’s stock worth $63,000 after purchasing an additional 381 shares during the period. Group One Trading LLC purchased a new position in shares of Merit Medical Systems in the 4th quarter worth about $77,000. Finally, Farther Finance Advisors LLC boosted its holdings in shares of Merit Medical Systems by 32.7% in the 3rd quarter. Farther Finance Advisors LLC now owns 1,056 shares of the medical instruments supplier’s stock worth $104,000 after buying an additional 260 shares during the last quarter. Hedge funds and other institutional investors own 99.66% of the company’s stock.

Insider Buying and Selling at Merit Medical Systems

In other news, CFO Raul Jr. Parra sold 12,451 shares of the stock in a transaction dated Friday, February 28th. The shares were sold at an average price of $98.81, for a total value of $1,230,283.31. Following the completion of the sale, the chief financial officer now owns 24,201 shares in the company, valued at $2,391,300.81. This represents a 33.97 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Stephen C. Evans sold 5,000 shares of the firm’s stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $105.31, for a total transaction of $526,550.00. Following the transaction, the director now directly owns 4,657 shares in the company, valued at $490,428.67. The trade was a 51.78 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 42,451 shares of company stock worth $4,244,333. Corporate insiders own 3.70% of the company’s stock.

Merit Medical Systems Company Profile

Merit Medical Systems, Inc designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions.